Coming October: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

Cleveland Clinic at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Cleveland Clinic brings 5 presentations to SITC 2026 in Phoenix. Its program centres on the VISTA immune checkpoint and on gene edits that keep CAR T cells from wearing out. One concrete item describes a faster, scalable way to manufacture purer CAR T cell products for chronic lymphocytic leukemia.

Organization	SITC 2026 Attendance
Cleveland Clinic Cleveland, OH
clevelandclinic.org Cancer centres & hospitals An academic medical center providing patient care and conducting clinical and biomedical research.	Poster Fri Nov 6 12:15–1:45pm 5:30–7pm An accelerated, scalable manufacturing platform generates highly purified and functionally superior CAR T cell products for chronic lymphocytic leukemia Exhibition Halls 4-6 · Poster 183 Cell therapy · Models & tech Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Blocking the VISTA/LRIG1 axis enhances antitumor CD8+ T cell responses and controls anaplastic thyroid tumor progression Exhibition Halls 4-6 · Poster 799 New agents · Tumor biology Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Dual CD38/CD39 Deletion Enhances Antitumor Efficacy Through Tumor Microenvironment Remodeling and Improved T-Cell Fitness Exhibition Halls 4-6 · Poster 741 New agents · Tumor biology Poster Fri Nov 6 12:15–1:45pm 5:30–7pm T cell-intrinsic VISTA enhances CD8+ T cell dysfunction and promotes resistance to CTLA-4 blockade Exhibition Halls 4-6 · Poster 789 Tumor biology · New agents Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm CARD8- and SRCAP-deficient CAR T-cells promote durable responses and limit functional exhaustion Exhibition Halls 4-6 · Poster 166 Cell therapy

Organization

SITC 2026 Attendance

Cleveland Clinic

Cleveland, OH

clevelandclinic.org

Cancer centres & hospitals

An academic medical center providing patient care and conducting clinical and biomedical research.

Poster

Fri Nov 6
12:15–1:45pm
5:30–7pm

An accelerated, scalable manufacturing platform generates highly purified and functionally superior CAR T cell products for chronic lymphocytic leukemia

Exhibition Halls 4-6 · Poster 183

Cell therapy · Models & tech